Announcements Trials
Browse Landscape

Phase

Phase NA 5

Status

Active not recruiting 3Recruiting 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 3Tumor-Agnostic 1

Conditions

Neoplasms 2Brain Neoplasms 2Neurologic Manifestations 1Neuralgia 1Glioma 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Transcranial Magnetic Stimulation × 1 year × Clear all
NCT07530536 2026-04-15

rTMS for Postoperative Brain Tumor Patients

Columbia University

Phase NA Recruiting
6 enrolled
CNS

Brain Neoplasms, Neurologic Manifestations

NCT03606161 2026-02-19

Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumors

M.D. Anderson Cancer Center

Phase NA Active not recruiting
32 enrolled
CNS

Brain Neoplasms

NCT07285525 2025-12-16

Accelerating Motor Recovery in Glioma Patients Using Postoperative nrTMS

Beijing Neurosurgical Institute

Phase NA Active not recruiting
43 enrolled
CNS

Glioma

NCT03219502 2025-10-14

rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy

M.D. Anderson Cancer Center

Phase NA Active not recruiting
56 enrolled
Tumor-Agnostic

Neoplasms

NCT07187219 2025-09-22

NeuroCanPain

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Recruiting
60 enrolled

Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡